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Abstract: Cyclodextrins, even the 6-membered α-cyclodextrin, are approved in the various
pharmacopoeias as pharmaceutical excipients for solubilizing and stabilizing drugs as well as
for controlling drug release. Recently α-cyclodextrin has also been marketed as health food with
beneficial effects on blood lipid profiles. However, the concentration of α-cyclodextrin used may
be very high in these cases, and its toxic attributes have to be seriously considered. The objective
of this study was to investigate the cytotoxicity of various, differently substituted α-cyclodextrin
derivatives and determine relationship between the structures and cytotoxicity. Three different
methods were used, viability tests (MTT assay and Real Time Cell Electronic Sensing on Caco-2
cells) as well as hemolysis test on human red blood cells. The effect of α-cyclodextrin derivatives
resulted in concentration-dependent cytotoxicity, so the IC50 values have been determined. Based
on our evaluation, the Real Time Cell Electronic Sensing method is the most accurate for describing
the time and concentration dependency of the observed toxic effects. Regarding the cytotoxicity on
Caco-2 cells, phosphatidylcholine extraction may play a main role in the mechanism. Our results
should provide help in selecting those α-cyclodextrin derivatives which have the potential of being
used safely in medical formulations.
Keywords: α-CD derivatives; cytotoxicity; Caco-2 cell line; hemolysis; RT-CES
1. Introduction
Cyclodextrins (CDs) are widely used excipients and still in the focus of drug development [1].
They are used as solubilizing factors, protective agents for light-sensitive drugs, and as a part
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of sustained release or drug delivery systems [2]. In some cases their stabilizing effect against
hydrolysis, oxidation, and microbial decomposition is utilized. They can also reduce the bitter taste
and unpleasant odor of the active compounds they include. There are several products on the market
(tablets, eye drops, transdermal patches, inhalers, etc.) which contain various CDs already approved
as pharmaceutical ingredients [3,4]. Most of these products contain β-CD or its hydroxypropyl,
and sulfobutyl derivatives, and only a few of the marketed formulations are produced with α-CD.
Nowadays, the favorable effect of orally administered α-cyclodextrins on blood lipids and weight
loss in healthy humans has been recognized [5]. Although α-CD like β-CD is practically not absorbed
from the gastrointestinal tract explaining the low oral toxicity, it might damage the cells of the
intestine, especially at the high applied concentrations used in these applications.
In the case of β-CD and its derivatives the toxic effects on living organisms are attributed
to the affinity to cholesterol [6]. In vitro studies have shown that this phenomenon is behind the
hemolytic effect of β-CDs, too [7]. The hemolytic effect of the non-cholesterol interacting α-CD was
explained by its capability of forming inclusion complexes with other membrane lipid constituents
such as phospholipids [8]. β-CDs have the most significant hemolytic activity; in the case of α- and
γ-derivatives it is less considerable while δ-CD is not hemolytic at all [9]. The substituents on the
CD derivatives may modify (increase or decrease) these effects depending on the lipid solubilizing
properties [9–12]. For instance, the hemolytic activity of α-CD derivatives on rabbit’s red blood cells
was enhanced by methylation and reduced by hydroxypropylation to follow the order of dimethyl
α-CD > α-CD > hydroxypropyl α-CD, which correlates with extraction of phospholipids including
sphingomyelin and of proteins from the membrane [13].
The hemolytic activity has been thoroughly investigated, but only a few studies on CDs’
cytotoxicity on other cell cultures have been reported. In pulmonary Calu-3 cells the methylated
β-CD was the most toxic, while the hydroxypropylated α-CD and β-CD, as well as the native γ-CD
proved to be safe for pulmonary drug delivery [14]. Evaluating the cytotoxicity of natural CDs
and hydroxypropylated derivatives on P388 murine leukaemic cells a similar order of cytotoxicity
was observed as in erythrocytes, in spite of the biological differences between the membranes of
these cells [8]. Toxic effects of several β-CD derivatives have been studied on Caco-2 cells, and like
red blood cells, a strong correlation was found between the cholesterol solubilizing effect and the
cytotoxicity [11,12]. The cytotoxic attributes depend not only on the properties of the CDs (number
of glucopyranose units, the chemical nature of the substituent, degree and pattern of substitution, the
HLB value, the applied concentration), but also on the duration of exposition, the presence of serum
components and density of the cells [15].
Not only pure CDs and their derivatives have been thoroughly investigated, but there are
several studies on the cytotoxicity of CD complexes, too. In early works of Uekama’s group it was
proved that complexation decreases the hemolytic activity of the drug encapsulated via decreasing
the concentration of the free drug able to interact with the cell membrane [16].
Some recent examples: sevoflurane-sulfobutylether-β-CDs showed no toxic effect on brain
microvascular endothelial cells [17], midazolam-trimethyl-β-CD complex was not toxic on cEND
cells [18]. On the other hand, there are examples when CDs do not influence the toxic effects of
drugs or show even enhanced effect on cancer cell lines. For instance, curcumin complexed by
β-CD was effective in inhibiting the cell proliferation in lung (A-459) and colon (SW-620) cancer cell
lines determined via MTT assay and enhanced in vitro toxicity (anticancer activity) of resveratrol
was observed when complexed by sulfobutyl ether β-CD on a human breast cancer cell line
(MCF-7) [19,20].
Nanoparticles containing CDs can go through the biological barriers and can be used as targeted
drug delivery systems [1]. For instance, β-CDs-poly(β-amino ester) formed non-toxic nanoparticles,
which can transport drugs across blood-brain barrier to treat chronic diseases in the brain [21].
Although, β-CDs are the most frequently used representatives of CDs in the pharmaceutical and food
industries, which implicitly results in a broad range toxicological studies of numerous derivatives,
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amphiphilic α-CDs can also form self-assembled nanoparticles [22]. Some fluorinated amphiphilic
α-CD successfully improved the stability of lipophilic antitumor drugs and presented high in vivo
tolerance [23].
In addition to the human blood cells we selected Caco-2 cells for our studies. Caco-2 cells are
considered a reliable model of orally administered pharmacons [21]. These cells are of colonic origin,
they express similar drug transporters to the human intestine [24,25] and exhibit a well differentiated
brush border on the apical surface and tight junctions [26]. A strong correlation was observed
between in vivo human absorption and in vitro Papp (apparent permeability coefficient) for a variety of
compounds encompassing transcellular, paracellular and carrier-mediated mechanisms [27]. Novel
in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability was developed
resulting in more reliable and stronger correlation between in vitro and in vivo data [28–30].
As there are only sporadic data on the cytotoxicity of α-CD derivatives we started a systematic
study aiming at evaluating the cytotoxicity of various α-CD derivatives on human erythrocytes
and Caco-2 cell monolayer and exploring the relationship between the structures and cytotoxicity.
Three different methods were used: viability tests (MTT assay and hemolysis test), and real time
cell electronic sensing assay (RT-CES). Viability tests are useful for obtaining information about the
concentration-dependence of the mechanism, and RT-CES is an adequate method to understand the
time-dependent mechanism of cell degradation.
2. Results and Discussion
2.1. Results
2.1.1. Hemolytic Effect of Different α-CD Derivatives
Native α-CD showed relatively high hemolytic effect as its HC50 value is 16 mM. TRIMEA was
much more hemolytic followed by the succinyl derivative. RAMEA caused hemolysis at similar
concentration to the non-substituted native α-CD. The order of hemolytic effect in case of methylation
is TRIMEA >> RAMEA > native α-CD. Among the non-ionic derivatives HPACD and AcACD were
not hemolytic up to 100 mM concentration.
In case of the ionic derivatives (phosphated, sulfated and carboxymethylated), high HC50 values
(>100 mM) were determined, which indicates that there is no severe hemolytic effect under these
circumstances (Figure 1A,B and Table 1).
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Figure 1. Hemolytic effect of non-ionic (A) and ionic (B) α-CD derivatives on human red blood cells. 
Hemolysis was expressed as the percentage of untreated control in the function of α-CD derivatives 
concentration. Negative control: PBS. Positive control: Purified water. Values presented are means ± SD. 
All data were obtained from three to five independent biological replicates and in the same experiments, 
four parallel concentrations were measured. 
Table 1. Comparison of α-CD derivatives cytotoxicity by different methods (MTT, RT-CES, hemolysis). 
Values are in mM, and expressed as mean ± SD. All data were obtained from three to five independent 
biological replicates and in the same experiments four parallel concentrations were measured. 
α-Cyclodextrin Derivative IC50 (MTT) IC50 (RT-CES) HC50 
native 46.1 ± 9.2 >25 16.0 ± 0.02 
RAMEA 78.6 ± 15.8 >25 15.5 ± 0.01 
TRIMEA 1.8 ± 0.8 >1 1.9 ± 0.01 
HPACD >100 >100 >100 
sulfated >100 >10 >100 
phosphated 7.8 ± 8.6 >10 >100 
CMACD >100 >25 >100 
SuACD 19.0 ± 8.8 >1 9.6 ± 0.03 
AcACD >100 >100 >100 
CMACDEp 58.4 ± 0.4 >10 24.5 ± 0.01 
2.1.2. Effect of α-CD Derivatives on Cell Viability 
The MTT assay showed similar toxic effects of α-CDs as the hemolysis test (Figures 2A,B, and 
Table 1), although some derivatives show remarkable differences (e.g., phosphated Na-salt). This 
phosphated sodium salt did not result in hemolysis but in MTT assay it was very toxic presenting IC50 
concentration of 7.8 mM. TRIMEA was the most toxic in both tests, while RAMEA was less toxic than 
the native α-CD. In the case of the two methylated derivatives the following order was recognized in 
toxicity: TRIMEA > native α-CD > RAMEA. On the other hand, HPACD, AcACD, sulfated, CMACD 
derivatives did not show toxic effect up to 100 mM just like they had no hemolytic effect either. 
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Figure 2. Effect of non-ionic (A) and ionic (B) α-CD derivatives on Caco-2 cell viability, determined 
by MTT-test. Cell viability was expressed as the percentage of untreated control in the function of  
α-CD derivatives concentration. Phosphate buffered saline (PBS) served as negative control and 
Triton X 100 (10% w/v) as positive control. Values presented are means ± SD. All data were obtained 
from three to five independent biological replicates and in the same experiments four parallel 
concentrations were measured. 
Several derivatives showed measurable IC50 values with the RT-CES method (Figure 3). Only 
HPACD and the AcACD derivative remained non-toxic up to 100 mM. For example, CMACD and 
sulfated ACD had no defined IC50 value by the MTT assay up to 100 mM after 30 min of treatment, 
but they were toxic when the exposition time was prolonged. In case of CMACDEp IC50 value could 
be determined with the previous method as well, but it decreased with the same time prolongation. 
  
Figure 2. Effect of non-ionic (A) and ionic (B) α-CD derivatives on Caco-2 cell viability, determined by
MTT-test. Cell viability was expressed as the percentage of untreated control in the function of α-CD
derivatives concentration. Phosphate buffered saline (PBS) served as negative control and Triton X 100
(10% w/v) as positive control. Values presented are means ˘ SD. All data were obtained from three
to five independent biological replicates and in the same experiments four parallel concentrations
were measured.
Several derivatives showed measurable IC50 values with the RT-CES method (Figure 3). Only
HPACD and the AcACD derivative remained non-toxic up to 100 mM. For example, CMACD and
sulfated ACD had no defined IC50 value by the MTT assay up to 100 m after 30 min of treatment,
but th y were toxic when the exposition time as prolonged. In case of CMACDEp IC50 value c uld
be determined with the previous method as well, but it decreased with the same time prolongation.
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Figure 3. Effect of non-ionic (A–F) and ionic (G–I) α-CD derivatives on Caco-2 cell viability, 
determined by Real Time Cell Electronic Sensing. Changes in cell index indicating viability of Caco-2 
cells up to 8 h treatment with different α-CD derivatives. Data are presented as mean ± S.D: n = 3 
parallel samples. Positive control: 1% Triton X-100 detergent. Negative control: PBS. 
Figure 3. Effect of non-ionic (A–F) and ionic (G–I) α-CD derivatives on Caco-2 cell viability,
determined by Real Time Cell Electronic Sensing. Changes in cell index indicating viability of Caco-2
cells up to 8 h treatment with different α-CD derivatives. Data are presented as mean ˘ S.D: n = 3
parallel samples. Positive control: 1% Triton X-100 detergent. Negative control: PBS.
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2.1.3. Indirect Verification of α-CD Cytotoxicity on Caco-2 Cells
Toxic effect of RAMEA and pre-formed inclusion complex of phosphatidylcholine:RAMEA was
compared by MTT assay on Caco-2 cells (Figure 4). Meanwhile RAMEA had its IC50 value of
78.6 mM, the complex had no definable IC50 up to 100 mM. Based on this difference we presumed
that α-CDs are really able to form inclusion complexes with phosphatidylcholine as one of the
main membrane constituents. This complexation can drive to membrane injuries and an increase
of membrane permeability, which can result in cell death.
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Figure 4. Comparison of toxicity on Caco-2 cells of RAMEA and RAMEA–phosphatidylcoline complex. 
Cell viability was expressed as the percentage of untreated control in the function of α-CD derivatives 
concentration. Values presented are means ± SD. All data were obtained from three to five independent 
biological replicates and in the same experiments four parallel concentrations were measured. 
2.2. Discussion 
In our study, the toxic effect of α-CD derivatives was investigated in vitro, on Caco-2 cells and 
in parallel on human erythrocytes by two different methods: viability tests (MTT and hemolysis) and 
impedance-based cytotoxicity assay (RT-CES). The IC50 and HC50 values were determined and 
correlated with the structures. Mainly, the MTT assay is based on the enzymatic conversion of MTT 
in the mitochondria, and detects early cytotoxicity compared to the hemolysis and RT-CES [31]. 
Hemolysis studies were a simple and rapid investigation to classify the CDs according to their 
cytotoxicity [15]. Both MTT and hemolysis tests are suitable for the morphological verification of the 
toxic concentrations of α-CD, but could not provide kinetic data [32]. They are endpoint determinations, 
and higher concentrations of excipients may interfere with these detection methods [33]. Real-time 
cell electronic sensing assay supports the determination of toxic concentration values in a broad time 
interval and is a convenient method to characterize the kinetic factors of cytotoxicity [34]. Toxic 
concentrations of, sulfated and carboxymethylated derivatives have been determined by RT-CES, but 
these compounds were not toxic by MTT and hemolysis methods. These differences may be explained 
by the longer exposition time compared to the other assays. It has been confirmed that real-time assay 
set up over a broad time frame, from minutes to several hours, is the most accurate method for the 
determination of toxic concentrations of α-CDs. 
Comparing the endpoint detection technique (MTT) and the non-invasive cell-based assay  
(RT-CES), the RT-CES method monitors cellular events in real-time without the incorporation of label or 
Figure 4. Comparison of toxicity on Caco-2 cells of RAMEA and RAMEA–phosphatidylcoline
complex. Cell viability was expressed as the percentage of untreated control in the function of α-CD
derivatives concentration. Values presented are means ˘ SD. All data were obtained from three
to five independent biological replicates and in the same experiments four parallel concentrations
were measured.
2.2. Discussion
In our study, the toxic effect of α-CD derivatives was investigated in vitro, on Caco-2 cells
and in parallel on human erythrocytes by two different methods: viability tests (MTT and
hemolysis) and impedance-based cytotoxicity assay (RT-CES). The IC50 and HC50 values were
determined and correlated with the structures. Mainly, the MTT assay is based on the enzymatic
conversion of MTT in the mitochondria, and detects early cytotoxicity compared to the hemolysis
and RT-CES [31]. Hemolysis studies were a simple and rapid investigation to classify the CDs
according to their cytotoxicity [15]. Both MTT and hemolysis tests are suitable for the morphological
verification of the toxic concentrations of α-CD, but could not provide kinetic data [32]. They
are endpoint determinations, and higher concentrations of excipients may interfere with these
detection methods [33]. Real-time cell electronic sensing assay supports the determination of toxic
concentration values in a broad time interval and is a convenient method to characterize the kinetic
factors of cytotoxicity [34]. Toxic concentrations of, sulfated and carboxymethylated derivatives have
been determined by RT-CES, but these compounds were not toxic by MTT and hemolysis methods.
These differences may be explained by the longer exposition time compared to the other assays. It has
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been confirmed that real-time assay set up over a broad time frame, from minutes to several hours, is
the most accurate method for the determination of toxic concentrations of α-CDs.
Comparing the endpoint detection technique (MTT) and the non-invasive cell-based assay
(RT-CES), the RT-CES method monitors cellular events in real-time without the incorporation of
label or transformation of cells. The MTT test is advisable only for the preliminary phase of a cell
death study. [32] Cell index shows the actual cell viability status and has been used in a number
of cell morphology, adhesion, cell proliferation and receptor activity studies. The resulting data
are biologically relevant because the elimination of labels brings the cells closer to physiological
conditions. It has been confirmed by the study of Ozsvári et al. [34] who observed similar results
of cytotoxicity using immortalized and rat primary cell lines in RT-CES experiments. The correlation
of in vitro cytotoxicity values IC50 and in vivo LD50 was verified in the study of Boyd et al. [35].
The limitations of conventional cell-based assays was demonstrated, because dye-based endpoint
detection only provides information about cell death (cell viability). Multiple parameters under
dynamic circumstances are needed for predicting human acute toxicity studies [36]. Real-time cell
electronic sensing assays provide reliable and dynamic cytotoxic parameters. The RT-CES method
was the most sensitive technique in our study to determine the safest concentration of different α-CD
derivatives. However, the cytotoxicity ranking obtained was the same as measured by MTT on the
same cell line (Caco-2) and determined by the hemolysis test on human erythrocytes. Correlation was
found among these tests based on different cell lines and different endpoints. The RT-CES method
has been validated by Zhu et al. [37]. High cytotoxicity information content and more predictable
kinetic data in human experiments were established.
Methylated (TRIMEA, RAMEA) and succinylated derivative (SuACD) showed the highest
cytotoxicity. Substitution of succinyl group and of methyl groups resulted in higher toxicity in
general, compared to the native α-CD. In the case of methylation, increased toxicity of TRIMEA
related to RAMEA has been explained by the difference in the substitution degree (DS 18 and
11, respectively). Higher DS with the same alkyl substituents probably increased the toxicity of
derivatives by reducing the free OH-groups. Ono et al. [38] investigated the cytotoxicity of maltosyl-
α-, β-CDs compared to native α-, β- and γ-CDs on Caco-2 cells. Native α-CD possessed the
highest cytotoxic attributes, but maltosyl groups suppressed the toxicity. The number and the
position of methyl groups also determined the cytotoxicity in the case of β-CD: above a number
of methyl substituents (DS ~10) the methylated β-CDs are highly toxic [11]. In our studies random
methylation decreased, but full substitution dramatically increased the toxicity. On the contrary, the
ionic substituents reduced the toxicity except phosphated α-CD. The viscosity of the solutions at
appropriate concentrations may be the cause of the relatively high toxicity of the polymer derivative
compared to its monomeric analog (CMACD). Hydroxypropyl and acetylated α-CDs are the most
favorable derivatives in our investigations.
It is well known that hydroxypropyl groups reduce the toxic properties of native α-, β- and
γ-CD [15,39]. However, the intensity of the cytotoxicity of CDs differs among the cell types, probably
due to the difference in the membrane compositions of the cells [40]. The possible mechanism
is that CDs can interact with plasma membranes by the extraction of different components into
their cavity via inclusion complex formation [8]. Significant correlation was observed between the
cytotoxicity determined by MTT on Caco-2 cells, hemolytic activity and the cholesterol complexation
capacity of various β-CDs [26]. β-CDs can extract cholesterol from the lipid rafts and randomly
methylated β-CDs can enter into intestinal epithelial cells by endocytosis [41]. The mechanism of
α-CD cytotoxicity is different because α-CD cannot include the large cholesterol molecules. The acyl
chain of phospholipids, however, fits into the tight hydrophobic cavity of smaller α-CD [13]. In our
indirect test the randomly methylated α-CD-phosphatidylcholine complex did not result in toxicity
on Caco-2 cell monolayer compared with the “empty” RAMEA, proving that there is no toxicity when
the cavity of the CDs is no more available. However, phosphatidylcholine extraction alone does
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not explain for the possessed cytotoxicity of α-CDs. Phosphatidylserine, phosphatidylethanolamine,
phosphatidylinositol and sphingomyelin also shows strong, but selective affinity for α-CDs [13].
Phospholipids can also be found in the erythrocyte external and internal bilayers in
different ratios [13]. This explains that some of the investigated α-CD derivatives demonstrated
concentration-dependent hemolysis. The highest hemolysis values were induced by methylated and
succinylated derivatives in accordance with the MTT results. Hydroxypropyl and acetyl groups in
the molecules diminished the toxicity (HC50 > 100 mM). The experiments of Motoyama et al. [42]
confirmed our results, because HPACD was also less toxic on rabbits’ red blood cells than α-CD.
All authors agree with the mechanism published by Irie et al. and Bost et al. [40,43]: inclusion
complexation of the membrane components induces their release and the lysis of the erythrocytes
or the irreversible damage of Caco-2 cells.
Comparing the HC50 with IC50, HC50 values are lower than IC50 values, which may indicate
thatα-CD derivatives interact more strongly with the erythrocyte membrane than with the membrane
of intestinal cells. The degree of the cytotoxicity of CDs toward Caco-2 cells increased in the order
of γ < β < α. [44]. In our previous study, lower IC50 values, that is higher toxic concentrations of
different β-CD derivatives, were measured (up to 200 mM) than in the case of α-CDs in accordance
with the above statement. Matilainen et al. [14,41] concluded that in terms of their toxicity changing
in the order of γ < β < α, γ-CD was the safest to the Calu3 cells, too. Interestingly, the cytotoxicity of
α-CD toward human corneal epithelial cells was even greater than that of dimethyl-β-CD (DIMEB),
one of the most toxic methylated β-CD derivative [44]. These results suggest that the intensity of
the cytotoxicity differs between the cell types due to the possibly different mechanism of membrane
constituent extraction.
3. Experimental Section
3.1. Materials and Methods
α-Cyclodextrin derivatives were generously offered by Cyclolab Ltd. (Cyclodextrin Research
& Development Laboratory, Budapest, Hungary). The derivatives used were: phosphated α-CD
sodium salt, carboxymethylated α-CD sodium salt (CMACD), sulfated α-CD carboxymethylated
α-CD polymer crosslinked with epichlorohydrin (CMACDEp), randomly methylated α-CD
(RAMEA), acetylated α-CD (AcACD), hexakis-(2,3,6-tri-O-methyl)-α-CD (TRIMEA), (2-hydroxy)
propyl α-CD (HPACD) and succinylated α-CD (SuACD). We investigated each α-CD in 7 different
concentrations: 0.01; 0.1; 1; 10; 25; 50 and 100 mM, with the exception of TRIMEA, which was not
soluble above 30 mM. The solid samples were dissolved in isotonic phosphate buffered saline (PBS),
purchased from Sigma–Aldrich (Budapest, Hungary) (Table 2.)
Table 2. Chemical description of used α-cyclodextrin derivatives (DS = substitution degree).
α-Cyclodextrin Derivative Short Name Molecular Formula Molecular Weight DS
native C36H60O30 972.84 0
random methyl RAMEA C47H82O30 1126.9 ~11
hexakis(2,3-tri-O-methyl) TRIMEA C54H96O30 1225.4 18
(2-hydroxy)propyl HPACD C49.5H87O34.5 1234.3 ~4.5
sulfated Na-salt sulfated C36H48O66S12Na12 2197.4 ~12
phosphated Na-salt phosphated C36H60O42P4Na4 1380.7 ~2–6
carboxymethylated Na-salt CMACD C48H63O36Na3 1212.9 ~3.5
succinylated SuACD C52H76O42 1373.2 ~4
acetylated AcACD C52H76O38 1267.1 ~7
carboxymethyl-α-CD CMACDEp 55 kDacrosslinked with epichlorohydrin
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3.2. Cell Culture
Caco-2 cell line was obtained from the European Collection of Cell Cultures (ECACC). Cells
were grown in plastic cell culture flasks in Dulbecco’s Modified Eagle’s Medium supplemented with
3.7 g/L NaHCO3, 10% (v/v) heat-inactivated fetal bovine serum (FBS), 1% (v/v) non-essential amino
acids solution, 1% (v/v) L-glutamine, 100 IU/mL penicillin, and 100 µg/mL streptomycin at 37 ˝C in
an atmosphere of 5% CO2. The cells were routinely maintained by regular passaging. For cytotoxic
and transport experiments, cells were used between passage numbers 20 and 40. The culture media
were replaced with fresh media in every 72 h [45,46].
3.3. Hemolysis Test
Hemolysis test was performed on fresh human blood. Erythrocytes were separated from citrated
blood by centrifugation at 2500ˆ g for 10 min.; washed three times with PBS and resuspended in
the same solution. Aliquots of the cell suspension with the respective red blood cell number of
5 ˆ 107 were added to the buffer solution (PBS pH 7.2) containing increasing concentrations of the
samples investigated in the study. After mixing them gently, each solution was incubated at 37 ˝C
for 10 min and then centrifuged at 5000ˆ g. Finally, the absorbance of the hemoglobin released
into the supernatant was measured at 540 nm with a FLUOstar OPTIMA Microplate Reader. The
percentage of hemolysis was expressed as the ratio of hemoglobin in the supernatant of the sample
solutions related to the hemoglobin concentration after the complete hemolysis of erythrocytes in
water. The dose-response curve was determined, and the concentration inducing hemolysis in 50%
of the erythrocyte population (HC50) was subsequently calculated [47].
3.4. MTT Cell Viability Assay
The MTT assay was performed on Caco-2 cells. The cells were seeded in 96 well plates until
the cell monolayer become confluent. The medium was changed once. After one week the medium
was removed, the cells were washed with PBS and exposed to increasing concentrations of α-CDs
dissolved in phosphate buffer saline (PBS). Cells were incubated for 30 min on 37 ˝C. Control
groups were processed equally and incubated without CD simultaneously. After treatment MTT dye
(3-(4,5-dimethylthiazol-2-yl))-2,5-diphenyltetrazolium bromide, 5 mg/mL) was applied to each well
for 3 h. MTT solution was removed and isopropanol-hydrochloric acid (25:1) was added to dissolve
the formed formazan crystals. The absorbance was measured at 570 nm against a 690 nm reference
with a FLUOstar OPTIMA Microplate Reader. Cell viability was expressed as the percentage of
untreated control [48].
3.5. Real-Time Cell Microelectronic Sensing (RT-CES)
Real-time cell electronic sensing (RT-CES) is a label-free technique for dynamic monitoring
of living cells [21]. The xCELLigence system (Roche, Basel, Switzerland) utilizes an electronic
readout called impedance to non-invasively quantify adherence cell proliferation and viability.
E-plates (Roche) contain gold microelectronic sensor arrays. The interaction between cells and
the electrode generates impedance response that correlates linearly with cell index reflecting cell
number, adherence and cell growth. This method is more sensitive and informative than colorimetric
end-point assays to test pharmaceutical excipients [32,49].
The E-plate was coated with 0.2% rat tail collagen–DW solution for 20 min at 37 ˝C. Culture
media (60 µL) was added to each well for background readings than 100 µL Caco-2 cell suspension
was dispensed at the density of 1.5 ˆ 104 cells/well. The cells were grown for 2 days. The medium
was changed to excipients solutions and the cells in the E-plate were kept in an incubator at 37 ˝C for
8 h and monitored every 5 min.
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The cell index at each time point was defined as (Rn ´ Rb)/15, where Rn is the cell-electrode
impedance of the well when it contains cells and Rb is the background impedance of the well with
the media alone.
3.6. Statistical Analysis
All data were obtained from three to five independent biological replicates and in the same
experiments, four parallel concentrations (wells) were measured. Raw data of cell viability (difference
of absorbance values at 570 nm against 690 nm), hemolysis (absorbance at 540 nm), and cell index
were compared with one-way ANOVA (using Geisser-Greenhouse correction) followed by Tukey
post-testing (because all data passed the D’Agostino and Pearson omnibus normality test). For this
purpose, data related to five concentrations were selected. Statistical significance for the difference
of means was assigned into one of five categories: p > 0.05 (not significant), p < 0.05 (*), p < 0.01 (**),
p < 0.001 (***) or p < 0.0001 (****). Data presented in this paper are expressed as mean˘ SD. Statistical
analysis was performed with GraphPad Prism 6.05, while other calculations were made by means of
Microsoft Office Excel 2013. The results of statistical analysis in the case of MTT and hemolysis tests
are shown in the Tables 3 and 4. The results of statistical analysis of RT-CES is presented in Figure 3.
Table 3. Comparison of cell viability values among the groups treated with different α-CD derivatives
(the number of asterisks indicates the level of statistical significance, p < 0.005 (*), p < 0.001 (**),
p < 0.001 (***), p < 0.0001 (****).
Logarithm of Concentrations ´4 ´3 ´2 ´1602 ´1301
HPACD vs. Phosphated **
HPACD vs. Polymer *
HPACD vs. SuACD *
Sulphated vs. Phosphated ** **** ****
Sulphated vs. SuACD **** ****
Phosphated vs. AcACD **
Phosphated vs. CMACD ** *** ****
Phosphated vs. SuACD ***
Phosphated vs. Polymer * ** ****
AcACD vs. Polymer *
RAMEA vs. TRIMEA * **** ****
RAMEA vs. HPACD * *** *** **
RAMEA vs. Sulphated * *** **
RAMEA vs. AcACD ** **** **** **
RAMEA vs. Phosphatidylcholine + RAMEA ** **** *** **
RAMEA vs. Phosphated **** **** ****
RAMEA vs. SuACD **** ****
RAMEA vs. Polymer *
native vs. RAMEA ** *** ****
native vs. TRIMEA **** ****
native vs. Phosphated *
native vs. SuACD ***
native vs. Sulphated **
native vs. CMACD **
native vs. Polymer *
TRIMEA vs. Sulphated **** ****
TRIMEA vs. Phosphated ***
TRIMEA vs. CMACD **** ****
TRIMEA vs. SuACD ****
TRIMEA vs. Polymer **** ****
SuACD vs. AcACD *
SuACD vs. Polymer **** ****
CMACD vs. SuACD **** ****
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Table 4. Comparison of hemolysis values among the groups treated with different α-CD derivatives
(the number of asterisks indicates the level of statistical significance. p < 0.005 (*), p < 0.001 (**),
p < 0.001 (***), p < 0.0001 (****).
Logarithm of Concentration ´2 ´1602 ´1301 ´1
native vs. RAMEA * ** **
native vs. TRIMEA **** **** ****
native vs. HPACD **** **** **** ****
native vs. Sulfated ** **** **** ****
native vs. Phosphated **** **** ****
native vs. CMACD **** **** ****
native vs. SuACD **** **** **** ****
native vs. AcACD ** **** **** ****
native vs. CMACDEp *** **** **** ****
RAMEA vs. TRIMEA **** * **** ****
RAMEA vs. HPACD **** **** **** ****
RAMEA vs. Sulfated **** **** **** ****
RAMEA vs. Phosphated **** **** ****
RAMEA vs. CMACD **** **** ****
RAMEA vs. SuACD **** **** **** ****
RAMEA vs. AcACD **** **** **** ****
RAMEA vs. CMACDEp **** **** **** ****
TRIMEA vs. HPACD **** **** **** ****
TRIMEA vs. Sulfated **** **** **** ****
TRIMEA vs. Phosphated **** **** **** ****
TRIMEA vs. CMACD **** **** **** ****
TRIMEA vs. SuACD **** **** **** ****
TRIMEA vs. AcACD **** **** **** ****
TRIMEA vs. CMACDEp **** **** **** **
HPACD vs. Phosphated ****
HPACD vs. CMACD ****
HPACD vs. SuACD **** **** **** ***
HPACD vs. AcACD *
HPACD vs. CMACDEp **** **** ****
Sulfated vs. Phosphated **
Sulfated vs. CMACD ***
Sulfated vs. SuACD **** **** **** *
Sulfated vs. CMACDEp **** **** ****
Phosphated vs. SuACD **** **** ****
Phosphated vs. AcACD **
Phosphated vs. CMACDEp **** **** **** ****
CMACD vs. SuACD **** **** ****
CMACD vs. AcACD **
CMACD vs. CMACDEp **** **** **** ****
SuACD vs. AcACD **** **** ****
SuACD vs. CMACDEp **** **** ****
AcACD vs. CMACDEp **** **** ****
4. Conclusions
It has been concluded that synthetic modifications on the glucopyranose rings of α-CD may
enhance or reduce its cytotoxic effects. Methyl and succinyl substitution may increase the toxicity
depending on the number of substituents, but hydroxypropyl α-CDs like β-CDs are suitable,
even for parenteral formulations and also acetylation definitely reduces the toxic effect. Real-time
kinetic assays provided quantitative, time dependent and more specific cytotoxicity values than the
conventional MTT viability and hemolysis tests. Our results indicate that some α-CDs could be safe
in pharmaceutical formulations. The same tests will be done on new generation of α-CD derivatives
with a well-defined substitution degree, in order to complete this structure-activity study.
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